FeedaMail: GrantsNet Funding News

	GrantsNet Funding News
	Department of Health and Human Services.National Institutes of Health.Collaborative Research in Integrative Cancer Biology and the Tumor Microenvironment (U01) With this funding opportunity announcement (FOA), the National Cancer Institute encourages new collaborative projects between investigators associated with the Integrative Cancer Biology Program (ICBP) or the Tumor Microenvironment Network (TMEN) and researchers who are not involved with the program with which they propose to collaborate. This FOA is designed to facilitate new projects in integrative cancer biology and/or tumor microenvironment research and to extend current research conducted in ICBP and TMEN programs through collaborations with a broader research community. Research projects proposed in response to this FOA should be collaborative and relevant to the missions of ICBP or TMEN programs. In addition to proposing new research, these projects are expected to leverage the resources and expertise currently available within ICBP and TMEN communities in order to extend and enhance the programs with new ideas, methods, expertise, and resources. Application budgets for direct costs up to $500,000 per year and project duration of up to 5 years may be requested. Read More » Department of Health and Human Services.National Institutes of Health.Diversity-promoting Institutions Drug Abuse Research Program (DIDARP) (R24) This funding opportunity announcement (FOA), issued by the National Institute on Drug Abuse, National Institutes of Health, encourages Resource-Related Research Project Grant (R24) applications from institutions that serve economically disadvantaged students and communities. Applications should propose to develop or strengthen the drug abuse research infrastructure at the institution and foster the research career development of a diverse cadre of faculty, students, and staff who are currently underrepresented in drug abuse research. This FOA will utilize the R24 grant mechanism. For this funding opportunity, budgets up to $350,000 in direct costs per year and time periods up to 5 years may be requested. Budgets for direct costs of up to $350,000 per year and project duration of up to 5 years may be requested. Read More » Department of Health and Human Services.National Institutes of Health.Nanoscience and Nanotechnology in Biology and Medicine (R21) This initiative, issued by the National Institutes of Health, encourages applications from institutions/organizations that apply nanoscience and nanotechnology approaches to address problems in biology and medicine. The purpose of this funding opportunity announcement (FOA) is to provide support for cutting-edge nanoscience and nanotechnology research that can lead to biomedical breakthroughs and new investigations into the diagnosis, treatment, and management of an array of diseases and traumatic injuries. Nanoscience and nanotechnology have the capacity to drive a new wave of medical innovation through the engineering of bioactive nanoscale structures, processes, and systems based on the advancement of our understanding of biology at the nanoscale. Therefore, this FOA will also support research projects that develop new or improved nanotechnology and nanoscience-based tools, methods, concepts, and devices that lead to a better understanding of basic biology in addition to conducting translational biomedical studies. Because this FOA utilizes the R21 grant mechanism, applications that focus on novel or exploratory approaches that are risky but have potentially a high impact are encouraged as well as proposed discovery research that may lead to new areas of biomedical investigations. The total project period for an application submitted in response to this funding opportunity may not exceed 2 years. Direct costs are limited to $275,000 over an R21 2-year period, with no more than $200,000 in direct costs allowed in any single year. Read More » Department of Health and Human Services.National Institutes of Health.Circadian Rhythms and Alcohol-induced Tissue Injury (R21) This funding opportunity announcement (FOA) encourages applications that propose to conduct mechanistic studies of the circadian rhythms involved in alcohol-induced organ damage. The circadian system comprises a complex feedback network that involves interactions between the central nervous system and peripheral tissues. The effects of alcohol on circadian rhythm and how alcohol's action is modulated by circadian rhythms have key implications for alcohol research. The central and peripheral oscillators, either individually or together, may play an important role in alcohol-induced tissue injury. The objective of this FOA is to understand the molecular mechanisms of alcohol-induced tissue damage that involve central and peripheral circadian rhythms, particularly their connection with metabolism and metabolic disorders. The total project period for an application submitted in response to this funding opportunity may not exceed 2 years. Although the size of award may vary with the scope of research proposed, it is expected that applications will stay within the budgetary guidelines for an exploratory/developmental project; direct costs are limited to $275,000 over an R21 2-year period, with no more than $200,000 in direct costs allowed in any single year. Read More » Department of Health and Human Services.National Institutes of Health.The Effect of Racial and Ethnic Discrimination/Bias on Health Care Delivery (R21) This funding opportunity announcement encourages the submission of research project grant applications from institutions/organizations that propose to: (1) improve the measurement of racial/ethnic discrimination in health care delivery systems through improved instrumentation, data collection, and statistical/analytical techniques; (2) enhance understanding of the influence of racial/ethnic discrimination in health care delivery and its association with disparities in disease incidence, treatment, and outcomes among disadvantaged racial/ethnic minority groups; and (3) reduce the prevalence of racial/ethnic health disparities through the development of interventions to reduce the influence of racial/ethnic discrimination on health care delivery systems in the United States. Direct costs are limited to $275,000 over an R21 2-year period, with no more than $200,000 in direct costs allowed in any single year. Read More » Department of Health and Human Services.National Institutes of Health.The Effect of Racial and Ethnic Discrimination/Bias on Health Care Delivery (R03) This funding opportunity announcement encourages the submission of research project grant applications from institutions/organizations that propose to: (1) improve the measurement of racial/ethnic discrimination in health care delivery systems through improved instrumentation, data collection, and statistical/analytical techniques; (2) enhance understanding of the influence of racial/ethnic discrimination in health care delivery and its association with disparities in disease incidence, treatment, and outcomes among disadvantaged racial/ethnic minority groups; and (3) to reduce the prevalence of racial/ethnic health disparities through the development of interventions to reduce the influence of racial/ethnic discrimination on health care delivery systems in the United States. This R03 grant mechanism supports pilot or feasibility studies and developmental research projects with the intention of obtaining sufficient preliminary data for a subsequent investigator-initiated Research Project Grant (R01) application. Budgets for direct costs of up to $50,000 per year and a project duration of up to 2 years may be requested for a maximum of $100,000 direct costs over a 2-year project period. Read More » The Edward N. and Della L. Thome Memorial Foundation..Edward N. and Della L. Thome Memorial Found., Bank of America, N.A. Trustee, Awards in Age-Related Macular Degeneration Research The Edward N. and Della L. Thome Memorial Foundation was created in 2002 to advance the health of older adults through the support of direct-service projects and medical research on diseases and disorders affecting older adults. In keeping with the foundation's mission, the goal of the awards program is to support translational research that will lead to improved therapies for individuals suffering from age-related macular degeneration (AMD). As steward of the Thome Memorial Foundation, Bank of America N.A. works with The Medical Foundation division's scientific review committees to select the most qualified candidates. Successful research proposals will extend recent basic research findings regarding the underlying mechanisms of AMD. Examples of funding areas include, but are not limited to, genetically engineered animal models, the discovery and testing of small-molecule therapies directed at promising targets including immune- or inflammation-related pathways associated with AMD, local drug delivery systems, and neuroprotective strategies. Basic research and clinical trials are outside the scope of this program. However, clinical studies that involve the evaluation of new imaging modalities with no potential risks to human subjects are eligible. Bank of America Merrill Lynch is a marketing name for the Retirement and Philanthropic Services businesses of Bank of America Corp. Banking and fiduciary activities are performed globally by banking affiliates of Bank of America Corp., including Bank of America, N.A., Member FDIC. For more information about the Thome Foundation's broader mission and funding, please visit www.bankofamerica.com/grantmaking. Read More » Department of Health and Human Services.National Institutes of Health.Research on Ethical Issues in Biomedical, Social and Behavioral Research (R01) The purpose of this funding opportunity announcement (FOA) is to support investigator-initiated Research Project Grant (R01) applications that propose to study high-priority bioethical challenges and issues associated with the types of biomedical, social, and behavioral research supported by the participating National Institutes of Health's institutes and centers (ICs). The Office of Behavioral and Social Sciences Research joins this FOA as part of its efforts to promote research on the behavioral and social aspects of health and illness. However, only participating ICs will provide direct grant support under this FOA. The maximum period is 5 years. Read More » Department of Health and Human Services.National Institutes of Health.Circadian Rhythms and Alcohol-induced Tissue Injury (R01) This funding opportunity announcement (FOA) encourages applications that propose to conduct mechanistic studies of the circadian rhythms involved in alcohol-induced organ damage. The circadian system comprises a complex feedback network that involves interactions between the central nervous system and peripheral tissues. The effects of alcohol on circadian rhythm and how alcohol's action is modulated by circadian rhythms have key implications for alcohol research. The central and peripheral oscillators, either individually or together, may play an important role in alcohol-induced tissue injury. The objective of this FOA is to understand the molecular mechanisms of alcohol-induced tissue damage that involve central and peripheral circadian rhythms, particularly their connection with metabolism and metabolic disorders. The award project period is 1 to 5 years. Read More » Department of Health and Human Services.National Institutes of Health.Model Systems for Fragile X Pre-Mutation and Primary Ovarian Insufficiency (FX-POI) (R21) The purpose of this funding opportunity announcement is to stimulate the development of new model systems and/or the thorough characterization of the ovarian phenotype of existing models of fragile X associated premature ovarian insufficiency (FX-POI). New and well-characterized models of FX-POI will help us to answer fundamental questions about the role of the FMR1 repeat expansion in ovarian function and reproductive aging, and allow the field to advance into evidence-based clinical research on fragile X premutation carriers who are at risk for POI. The combined budget for direct costs for the 2-year project period may not exceed $275,000. No more than $200,000 may be requested in any single year. Read More »
	Delievered to you by Feedamail. Unsubscribe